PA
DPLO

Perceptive Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Perceptive Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-30,658
Closed -$454K – 167
2017
Q2 		$454K Buy
+30,658
New +$511K 0.02% 117
2016
Q3 		– Sell
-2,175
Closed -$76K – 224
2016
Q2 		$76K Buy
+2,175
New +$68.4K 0.01% 152

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors's DPLO Position: Q3 2017 in Review

Perceptive Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2017, closing a stake of 30,658 shares — an estimated $454K sold.

Perceptive Advisors first reported a position in DPLO in Q2 2016 and held it in 2 quarters. The position peaked at $454K in Q2 2017. 165 funds tracked by Wall St. Rank hold DPLO as of Q3 2017.

  • Perceptive Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2017 after selling out during the quarter.
  • Perceptive Advisors sold 30,658 DIPLOMAT PHARMACY, INC. shares in Q3 2017, an estimated $454K.
  • Perceptive Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and held it in 2 quarters.
  • Perceptive Advisors's DIPLOMAT PHARMACY, INC. position peaked at $454K in Q2 2017.
  • 165 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2017.

Based on Perceptive Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.